Skip to search formSkip to main contentSkip to account menu

Lipanor

Known as: Hyperlipen, Modalim 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ciprofibrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Experimental studies of the hypolipidemic properties of pollen
Experiments on white rats with a model of “chronic” (two months) hyperlipidemia demonstrated the ability of pollen to produce… 
2006
2006
Separation of fibrate-type antihyperlipidemic drugs by capillary electrophoresis and their quantitation in pharmaceuticals.
2006
2006
Pharmacologically active substances from Ambrosia artemisiifolia. Part 2
A new scheme of the isolation of all fractions of polyphenolic compounds from wormwood-leaved ambrosia (Ambrosia artemisiifolia L… 
2000
2000
[Ciprofibrate in the treatment of combined hyperlipoproteinemia. Results in more than 600 patients from 23 centers in the Czech Republic].
A total of 633 patients with combined hyperlipoproteinaemia from 23 centres in the Czech Republic met the criteria for assessment… 
1998
1998
[Lipanor treatment of atherogenic hyperlipoproteinemia].
AIM The study of the hypolipidemic efficiency, safety and tolerance of ciprofibrate (lipanor) in therapy of atherogenic… 
1996
1996
[A trial of the use of the hypolipidemic preparation Lipanor (ciprofibrate) in patients with primary hyperlipidemia].
Out of 12 patients with primary hyperlipidemia (HL) included in the study ischemic heart disease was diagnosed in 4 and… 
1996
1996
A trial of the use of the hypolipidemic preparation Lipanor (ciprofibrate) in patients with primary hyperlipidemia
: Out of 12 patients with primary hyperlipidemia (HL) included in the study ischemic heart disease was diagnosed in 4 and… 
1991
1991
[Side effects of fibrates (except liver and muscle)].
If the iatrogenic acute muscular syndromes (rhabdomyolysis) and hepatic diseases following hypolipidemic drugs therapy are very… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)